Balyasny Asset Management’s Medtronic MDT Stock Holding History

Balyasny Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.61M	Sell	110,900 -57,000	-34%	-$5.46M	0.01%	1052
2025 Q4	$16.1M	Sell	167,900 -32,800	-16%	-$3.19M	0.02%	827
2025 Q3	$19.1M	Buy	200,700 +104,100	+108%	+$9.57M	0.02%	737
2025 Q2	$8.42M	Buy	96,600 +42,900	+80%	+$3.64M	0.01%	1042
2025 Q1	$4.83M	Sell	53,700 -32,200	-37%	-$2.88M	0.01%	1260
2024 Q4	$6.86M	Buy	85,900 +41,300	+93%	+$3.58M	0.01%	1124
2024 Q3	$4.02M	Buy	+44,600	New	+$3.75M	0.01%	1360
2024 Q2	–	Sell	-96,700	Closed	-$8.43M	–	2900
2024 Q1	$8.43M	Buy	96,700 +93,700	+3,123%	+$8M	0.01%	1006
2023 Q4	$247K	Buy	+3,000	New	+$229K	﹤0.01%	2242
2021 Q3	–	Sell	-6,700	Closed	-$832K	–	2235
2021 Q2	$832K	Buy	+6,700	New	+$841K	﹤0.01%	1371
2017 Q4	–	Sell	-550,000	Closed	-$42.8M	–	2205
2017 Q3	$42.8M	Buy	+550,000	New	+$45.7M	0.17%	167
2016 Q2	–	Sell	-150,000	Closed	-$11.3M	–	1339
2016 Q1	$11.3M	Buy	+150,000	New	+$11.3M	0.07%	366

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management's MDT Position: Q1 2026 in Review

Balyasny Asset Management reduced its Medtronic (MDT) stake by 96% in Q1 2026, selling an estimated $103M and leaving 40,328 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Balyasny Asset Management first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $220M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Balyasny Asset Management held 40,328 shares of Medtronic worth $3.49M as of Q1 2026.
Balyasny Asset Management sold 1,077,388 Medtronic shares in Q1 2026, an estimated $103M.
Medtronic made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1528 holding.
Balyasny Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
Balyasny Asset Management's Medtronic position peaked at $220M in Q2 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.